Traws Pharma, Inc.
TRAWNASDAQHealthcare● Active
$1.37
+$0.00(+0.00%)
Market Cap$12522441
P/E Ratio—
52W High$3.27
52W Low$1
Traws Pharma, Inc.（TRAW）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · TRAW · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.79M | $0.23M | $0.23M | $0.23M | $0.23M |
| Cost of Revenue | $0.00M | $0.01M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $2.79M | $0.21M | $0.23M | $0.23M | $0.23M |
| Gross Margin %(computed) | 100.00% | 94.69% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $12.14M | $130.31M | $11.43M | $11.41M | $7.30M |
| G&A Expenses | $8.52M | $12.29M | $9.09M | $8.45M | $9.43M |
| Total Operating Expenses | $20.66M | $49.56M | $20.52M | $19.85M | $16.72M |
| Operating Income | ($17.88M) | ($49.35M) | ($20.30M) | ($19.63M) | ($16.50M) |
| Operating Margin %(computed) | -640.68% | — | — | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Income Before Tax | $9.17M | ($166.52M) | ($18.95M) | ($18.96M) | ($16.16M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | $9.17M | ($54.67M) | ($18.95M) | ($18.96M) | ($16.16M) |
| Net Margin %(computed) | 328.67% | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.83 | $-35.21 | $-22.57 | $-22.68 | $-24.01 |
| Wtd Avg Shares | 8.23M | 1.55M | 0.84M | 0.84M | 0.67M |
| EBITDA | ($17.81M) | ($166.51M) | ($20.28M) | ($19.61M) | ($16.48M) |
| EBITDA Margin %(computed) | -638.49% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Traws Pharma, Inc.
关于Traws Pharma, Inc.（TRAW）损益表
Traws Pharma, Inc.（TRAW）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，TRAW实现营收$0.00B，毛利润$0.00B（毛利率100.00%），净利润$0.01B（净利率328.67%）。
常见问题
TRAW · 4 问Traws Pharma, Inc.（TRAW）2025财年营收为$0.00B，同比up1134.5%。
TRAW revenueTRAW salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09